ID   UKRV-Mel-05
AC   CVCL_A703
SY   UKRV-Mel-5
DR   Cosmic; 906468
DR   Cosmic; 1846692
DR   Cosmic; 2686504
DR   ESTDAB; ESTDAB-145
DR   Wikidata; Q54990560
RX   PubMed=15760917;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-145
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D3S1358: 16,17
ST   D5S818: 9
ST   D7S820: 10
ST   FGA: 21
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
RX   PubMed=15760917; DOI=10.1093/carcin/bgi066;
RA   Bloethner S., Chen B.-W., Hemminki K., Mueller-Berghaus J., Ugurel S.,
RA   Schadendorf D., Kumar R.;
RT   "Effect of common B-RAF and N-RAS mutations on global gene expression
RT   in melanoma cell lines.";
RL   Carcinogenesis 26:1224-1232(2005).
//
RX   PubMed=23348503; DOI=10.1126/science.1230062;
RA   Horn S., Figl A., Rachakonda P.S., Fischer C., Sucker A., Gast A.,
RA   Kadel S., Moll I., Nagore E., Hemminki K., Schadendorf D., Kumar R.;
RT   "TERT promoter mutations in familial and sporadic melanoma.";
RL   Science 339:959-961(2013).
//